CoChat

Necrosis related HIF-1α expression predicts prognosis in patients with endometrioid endometrial carcinoma

Open access
Seeber, Laura MS, Horrée, Nicole, van der Groep, Petra, van der Wall, Elsken, Verheijen, René HM, van Diest, Paul J · 2010 · BMC Cancer

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Abstract

Background: Hypoxia inducible factor 1α (HIF-1α) plays an essential role in the adaptive response of cells to hypoxia and is associated with aggressive tumour behaviour. We have shown p27 kip1, which is generally reduced in endometrial cancer, to be re-expressed in hypoxic regions. This possibly contributes to survival of cancer cells. The aim of this study was to evaluate the prognostic value of HIF-1α and p27 kip expression in patients with endometrioid endometrial cancer. Methods: Expression levels of HIF-1α, CAIX, Glut-1, and p27 kip1 were analyzed by immunohistochemistry. Percentage of positive cells, staining pattern (perinecrotic, diffuse, or mixed) and presence of necrosis were noted. Results: Necrosis was correlated with shortened disease free survival (DFS) (p = 0.008) and overall survival (OS) (p = 0.045). For DFS, perinecrotic HIF-1α expression was also prognostic (p = 0.044). Moreover, high p27 kip1 expression was an additional prognostic factor for these patients with perinecrotic HIF-1α expression. In multivariate Cox regression, perinecrotic HIF-expression emerged as an independent prognostic factor. Perinecrotic HIF-1α expression was significantly associated with CAIX and Glut-1 expression, pointing towards functional HIF-1. Conclusions: In patients with endometrioid endometrial cancer, necrosis and necrosis-related expression of HIF-1α are important prognostic factors. More aggressive adjuvant treatment might be necessary to improve the outcome of patients with these characteristics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2407-10-307

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Immunohistochemical staining of HIF-1α, CAIX, Glut-1 and p27kip1 in endometrioid endometrial carcinoma. Typical patterns are shown: A) perinecrotic HIF-1α expression (10× magnification). B) Diffuse HIF-1α expression (10× magnification). C) Diffuse p27kip1 expression (10× magnification). D) Perinecrotic Glut-1 expression (10× magnification) E) Membrane CAIX expression (20× magnification). Asterisk indicates necrosis.
Figure 1 Immunohistochemical staining of HIF-1α, CAIX, Glut-1 and p27kip1 in endometrioid endometrial carcinoma. Typical patterns are shown: A) perinecrotic HIF-1α expression (10× magnification). B) Diffuse HIF-1α expression (10× magnification). C) Diffuse p27kip1 expression (10× magnification). D) Perinecrotic Glut-1 expression (10× magnification) E) Membrane CAIX expression (20× magnification). Asterisk indicates necrosis.CC BY · PubMed Central
Figure 2 Kaplan-Meier survival curves illustrating disease-free survival and overall survival for endometrioid endometrial carcinoma patients (n = 93) with tumour necrosis (A, B) and patients with perinecrotic type HIF-1α expression (C, D). E and F show the survival for the patients with perinecrotic HIF-1α expression (n = 51) and high p27kip1 expression. Stage and grade show prognostic value as expected in G - J.
Figure 2 Kaplan-Meier survival curves illustrating disease-free survival and overall survival for endometrioid endometrial carcinoma patients (n = 93) with tumour necrosis (A, B) and patients with perinecrotic type HIF-1α expression (C, D). E and F show the survival for the patients with perinecrotic HIF-1α expression (n = 51) and high p27kip1 expression. Stage and grade show prognostic value as expected in G - J.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 55

Metadata

Authors
Seeber, L. M., Horrée, N., van der Groep, P., van der Wall, E., Verheijen, R. H., & van Diest, P. J.
Affiliations
University Medical Center Utrecht (NL)
Venue
BMC Cancer
Published
2010-06-19
Volume
10
Issue
1
Pages
307-307
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2014648810
Cited by
55
References
49
Citations by year
2025: 3 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 5 · 2018: 1 · 2017: 1 · 2016: 7 · 2015: 8 · 2014: 6 · 2013: 5 · 2012: 8
FWCI
1.61
Type
journal article
Language
en
Open access
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
KWF Kankerbestrijding
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords
HIF-1α, endometrioid endometrial cancer, tumor necrosis, p27, CAIX, GLUT1, prognostic factors, disease-free survival, overall survival, tumor hypoxia
MeSH terms
Carbonic Anhydrase IX, Adult, Aged, Aged, 80 and over, Hypoxia, Antigens, Neoplasm, Carbonic Anhydrases, Female, Humans, Immunoenzyme Techniques, Middle Aged, Necrosis, Biomarkers, Tumor, Survival Rate, Endometrial Neoplasms, Carcinoma, Endometrioid, Intracellular Signaling Peptides and Proteins, Cyclin-Dependent Kinase Inhibitor p27, Glucose Transporter Type 1, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Necrosis related HIF-1α expression predicts prognosis in patients with endometrioid endometrial carcinoma. https://app.cochat.ai/papers/10.1186/1471-2407-10-307
The paper
Seeber, L. M., Horrée, N., van der Groep, P., van der Wall, E., Verheijen, R. H., & van Diest, P. J. (2010). Necrosis related HIF-1α expression predicts prognosis in patients with endometrioid endometrial carcinoma. BMC Cancer. https://doi.org/10.1186/1471-2407-10-307

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.